Related Experiment Video
Updated: Jan 7, 2026

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
457
Enhancing prognostic accuracy in sepsis-induced cardiomyopathy: a machine learning approach.
Xiang Li1,2, Huixin Cheng3, Dina Ainiwaer1
1Department of Pathophysiology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
European Journal of Medical Research
|December 13, 2025
Summary
Sepsis-induced cardiomyopathy (SIMD) mortality risk can be predicted using a new logistic regression model. This model identifies key factors like illness severity, age, and liver function for early risk stratification in critical care.
Area of Science:
- Critical Care Medicine
- Cardiology
- Data Science in Healthcare
Background:
- Sepsis-induced cardiomyopathy (SIMD) is a serious complication of sepsis, leading to myocardial dysfunction and high mortality.
- Existing prognostic tools inadequately address SIMD's complex pathophysiology, necessitating advanced predictive models.
Purpose of the Study:
- To develop and validate a robust prognostic model for predicting short-term mortality in adult patients with SIMD.
- To identify key predictors of mortality in SIMD patients.
Main Methods:
- Retrospective analysis of 1068 adult SIMD patients from the MIMIC-IV database.
- Feature selection using Boruta, LASSO, and RFECV, followed by logistic regression model development.
- Model performance evaluated using ROC curves, calibration curves, decision curve analysis, and SHAP for interpretability.
Main Results:
- Seven predictors identified: APS III, age, CCI, cerebrovascular disease, ALP, lactate, and CK-MB.
- The logistic regression model demonstrated strong discrimination (AUC up to 0.88) and calibration (K-S > 0.45).
- Key predictors of mortality included acute illness severity (APS III), age, and hepatic dysfunction (ALP).
Conclusions:
- A validated logistic regression model effectively predicts short-term mortality in SIMD patients.
- The model highlights acute illness severity, aging, and hepatic dysfunction as primary determinants of mortality.
- This tool aids early risk stratification in critical care settings for SIMD patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Cardiomyopathy V: Interprofessional Care
305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
